loadpatents
name:-0.028373003005981
name:-0.023698091506958
name:-0.025245904922485
ADVERIO PHARMA GMBH Patent Filings

ADVERIO PHARMA GMBH

Patent Applications and Registrations

Patent applications and USPTO patent grants for ADVERIO PHARMA GMBH.The latest application filed is for "process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine".

Company Profile
22.31.37
  • ADVERIO PHARMA GMBH - Leverkusen DE
  • Adverio Pharma GmbH - Schoenefeld DE
  • ADVERIO PHARMA GMBH - Schonefeld DE
  • Adverio Pharma GmbH - Schoenefeld, OT DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted 5-fluoro-1H-pyrazolopyridines and their use
Grant 11,439,642 - Follmann , et al. September 13, 2
2022-09-13
Process For Manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine
App 20220089554 - Fey; Peter ;   et al.
2022-03-24
Forms Of Methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl Carbamate
App 20220073515 - KEIL; Birgit ;   et al.
2022-03-10
Methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyrid- In-3-yl]pyrimidin-5-yl}carbamate Active Compound Product Having Improved Properties, Production And Formulation Thereof
App 20220048907 - Fey; Peter ;   et al.
2022-02-17
Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimid- ino-5-yl}methyl carbamate
Grant 11,203,593 - Keil , et al. December 21, 2
2021-12-21
Substituted 5-fluoro-1h-pyrazolopyridines And Their Use
App 20200397785 - Follmann; Markus ;   et al.
2020-12-24
Substituted 5-fluoro-1H-pyrazolopyridines and their use
Grant 10,736,896 - Follmann , et al. A
2020-08-11
Forms Of Methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl Carbamate
App 20200239469 - KEIL; Birgit ;   et al.
2020-07-30
Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate
Grant 10,662,188 - Keil , et al.
2020-05-26
Hydrates of substituted 5-fluoro-1H-pyrazolopyridines
Grant 10,633,356 - Fey , et al.
2020-04-28
Intermediates and process for preparing intermediates in the production of substituted pyrazolopyridines
Grant 10,633,357 - Fey
2020-04-28
Process for preparing methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]p- yrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
Grant 10,570,130 - Mais , et al. Feb
2020-02-25
Method of Identifying a Subgroup of Patients Suffering from DcSSc which Benefits from a Treatment with sGC Stimulators and sGC A
App 20190371469 - SANDNER; Peter ;   et al.
2019-12-05
Process For Preparing Methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]p- Yrimidin-5-yl}methylcarbamate A
App 20190284186 - MAIS; Franz-Josef ;   et al.
2019-09-19
Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparing
Grant 10,364,229 - Fey , et al.
2019-07-30
Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridin-3-yl]pyrimid- in-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
Grant 10,351,562 - Mais , et al. July 16, 2
2019-07-16
Hydrates Of Substituted 5-fluoro-1h-pyrazolopyridines
App 20190177287 - FEY; Peter ;   et al.
2019-06-13
Intermediates And Process For Preparing Intermediates In The Production Of Substituted Pyrazolopyridines
App 20190177288 - FEY; Peter
2019-06-13
Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)
Grant 10,189,856 - Hirth-Dietrich , et al. Ja
2019-01-29
Forms Of Methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl Carbamate
App 20180370970 - KEIL; Birgit ;   et al.
2018-12-27
Process For Preparing Methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimid- In-5-yl}methylcarbamate And Its Purification For Use As Pharmaceutically Active Compound
App 20180282329 - MAIS; Franz-Josef ;   et al.
2018-10-04
Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
Grant 10,087,183 - Keil , et al. October 2, 2
2018-10-02
Substituted 5-fluoro-1h-pyrazolopyridines And Their Use
App 20180263981 - FOLLMANN; Markus ;   et al.
2018-09-20
Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimid- in-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
Grant 10,030,014 - Mais , et al. July 24, 2
2018-07-24
Substituted 5-flouro-1H-pyrazolopyridines and their use
Grant 9,993,476 - Follmann , et al. June 12, 2
2018-06-12
Crystalline Substituted 5-fluoro-1h-pyrazolopyridines And Process For Preparing
App 20180065942 - FEY; Peter ;   et al.
2018-03-08
Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Grant 9,845,300 - Fey December 19, 2
2017-12-19
Forms Of Methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl Carbamate
App 20170334910 - KEIL; Birgit ;   et al.
2017-11-23
Substituted 5-fluoro-1h-pyrazolopyridines And Their Use
App 20170273977 - FOLLMANN; Markus ;   et al.
2017-09-28
Process For Preparing Substituted 5-fluoro-1h-pyrazolopyridines
App 20170158652 - FEY; Peter ;   et al.
2017-06-08
Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Grant 9,604,948 - Fey , et al. March 28, 2
2017-03-28
Substituted 5-fluoro-1h-pyrazolopyridines And Their Use
App 20160129004 - FOLLMANN; Markus ;   et al.
2016-05-12
Substituted 5-fluoro-1H-pyrazolopyridines and their use
Grant 9,266,885 - Follmann , et al. February 23, 2
2016-02-23
Process For Preparing Substituted 5-fluoro-1h-pyrazolopyridines
App 20160009671 - FEY; Peter
2016-01-14
Forms Of Methyl Methyl Carbamate
App 20150376184 - KEIL; Birgit ;   et al.
2015-12-31
Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Grant 9,150,573 - Fey October 6, 2
2015-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed